Comparative Analysis Of Anticholinergics Prescribed To Elderly Patients At A Korean Long-Term Care Facility According To Beers Criteria 2003, 2012, And 2015 And Anticholinergic-Burden Rating Scales: A Cross-Sectional Retrospective Study

References

• Ageing and health. World Health Organization. Available from: https://www.who.int/en/news-room/fact-sheets/detail/ageing-and-health Accessed 113, 2019.
   Google Scholar
• Prasad S, Sung B, Aggarwal BB. Age-associated chronic diseases require age-old medicine: role of chronic inflammation. Prev Med. 2012;54(Suppl):S29–S37. doi:10.1016/j.ypmed.2011.11.01122178471
   PubMed Web of Science ®Google Scholar
• Page RL 2nd, Linnebur SA, Bryant LL, Ruscin JM. Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging. 2010;5:75–87.20396637
   PubMed Web of Science ®Google Scholar
• Naples JG, Marcum ZA, Perera S, et al. Concordance between anticholinergic burden scales. J Am Geriatr Soc. 2015;63(10):2012–2014. doi:10.1111/jgs.2015.63.issue-10
   Web of Science ®Google Scholar
• Fox C, Richardson K, Maidment ID, et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc. 2011;59(8):1477–1483. doi:10.1111/j.1532-5415.2011.03491.x21707557
   PubMed Web of Science ®Google Scholar
• Felton M, Hanlon JT, Perera S, Thorpe JM, Marcum ZA. Racial differences in anticholinergic use among community-dwelling elders. Consult Pharm. 2015;30(4):240–245. doi:10.4140/TCP.n.2015.24025893702
   PubMedGoogle Scholar
• Gray SL, Hanlon JT. Anticholinergic medication use and dementia: latest evidence and clinical implications. Ther Adv Drug Saf. 2016;7(5):217–224. doi:10.1177/204209861665839927695623
   PubMedGoogle Scholar
• Durán CE, Azermai M, Vander Stichele RH. Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol. 2013;69(7):1485–1496. doi:10.1007/s00228-013-1499-323529548
   PubMed Web of Science ®Google Scholar
• Kumpula EK, Bell JS, Soini H, Pitkälä KH. Anticholinergic drug use and mortality among residents of long-term care facilities: a prospective cohort study. J Clin Pharmacol. 2011;51(2):256–263. doi:10.1177/009127001036841020489026
   PubMed Web of Science ®Google Scholar
• The American Geriatrics Society 2015 Beers Criteria Updated Expert Panel. American geriatrics society 2015 updated beers critiera for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–2246. doi:10.1111/jgs.1370226446832
   PubMed Web of Science ®Google Scholar
• Salbu RL, Feuer J. A closer look at the 2015 Beers critiera. J Pharm Pract. 2017;30(4):419–424. doi:10.1177/089719001666307227599749
   PubMedGoogle Scholar
• Boustani M, Campbell N, Munger S, Maidment I, Fox C. Impact of anticholinergics on the aging brain: a review and pratical application. Aging Health. 2008;4(3):311–320. doi:10.2217/1745509X.4.3.311
   Google Scholar
• Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008;168(5):508–513. doi:10.1001/archinternmed.2007.10618332297
   PubMedGoogle Scholar
• Chew ML, Mulsant BH, Pollock BG, et al. Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc. 2008;56(7):1333–1341. doi:10.1111/j.1532-5415.2008.01737.x18510583
   PubMed Web of Science ®Google Scholar
• Carnahan RM, Lund BC, Perry PJ, Pollock BG, Culp KR. The anticholinergic drug scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol. 2006;46(12):1481–1486. doi:10.1177/009127000629212617101747
   PubMed Web of Science ®Google Scholar
• Ehrt U, Broich K, Larsen JP, Ballard C, Aarsland D. Use of drugs with anticholinergic effect and impact on cognition in parkinson’s disease: a cohort study. J Neurol Neurosurg Psychiatry. 2010;81(2):160–165. doi:10.1136/jnnp.2009.18623919770163
   PubMed Web of Science ®Google Scholar
• Villalba-Moreno AM, Alfaro-Lara ER, Pérez-Guerrero MC, Nieto-Martín MD, Santos-Ramos B. Systematic review on the use of anticholinergic scales in poly pathological patients. Arch Gerontol Geriatr. 2016;62:1–8. doi:10.1016/j.archger.2015.10.00226518612
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhou S, Pan K, et al. Potentially inappropriate medications in hospitalized older patients: a cross-sectional study using the Beers 2015 criteria versus the 2012 criteria. Clin Interv Aging. 2017;12:1697–1703. doi:10.2147/CIA.S14600929066875
   PubMed Web of Science ®Google Scholar
• Momin TG, Pandya RN, Rana DA, Patel VJ. Use of potentially inappropriate medications in hospitalized elderly at a teaching hospital: a comparison between Beers 2003 and 2012 criteria. Indian J Pharmacol. 2013;45(6):603–607. doi:10.4103/0253-7613.12137224347769
   PubMed Web of Science ®Google Scholar
• Baldoni Ade O, Ayres LR, Martinez EZ, Dewulf Nde L, Dos Santos V, Pereira LR. Factors associated with potentially inappropriate medications use by the elderly according to Beers criteria 2003 and 2012. Int J Clin Pharm. 2014;36(2):316–324. doi:10.1007/s11096-013-9880-y24271923
   PubMed Web of Science ®Google Scholar
• Pasina L, Djade CD, Lucca U, et al. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study. Drugs Aging. 2013;30(2):103–112. doi:10.1007/s40266-012-0044-x23239364
   PubMed Web of Science ®Google Scholar
• Salahudeen MS, Duffull SB, Nishtala PS. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr. 2015;15:31. doi:10.1186/s12877-015-0029-925879993
   PubMed Web of Science ®Google Scholar
• Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–2724. doi:10.1001/archinte.163.22.271614662625
   PubMed Web of Science ®Google Scholar
• Campanelli CM. American geriatrics society updated Beers criteria for potentially inappropriate medication use in older adults: the American Geriatrics Society 2012 Beers criteria update expert panel. J Am Geriatr Soc. 2012;60(4):616–631. doi:10.1111/j.1532-5415.2012.03923.x22376048
   PubMed Web of Science ®Google Scholar
• Sittironnarit G, Ames D, Bush AI, et al. Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study. Dement Geriatr Cogn Disord. 2011;31(3):173–178. doi:10.1159/00032517121389718
   PubMed Web of Science ®Google Scholar
• Han L, Agostini JV, Allore HG. Cumulative anticholinergic exposure is associated with poor memory and executive function in older men. J Am Geriatr Soc. 2008;56(12):2203–2210. doi:10.1111/j.1532-5415.2008.02009.x19093918
   PubMed Web of Science ®Google Scholar
• Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. Bmj. 2006;332(7539):455–459. doi:10.1136/bmj.38740.439664.DE16452102
   PubMed Web of Science ®Google Scholar
• Trevethan R. Sensitivity, specificity, and predictive values: foundations, pliabilities, and pitfalls in research and practice. Front Public Health. 2017;5:307 eCollection 2017. doi:10.3389/fpubh.2017.00307.29209603
   PubMed Web of Science ®Google Scholar
• Mo L, Yang X, He J, Dong B. Evaluation of potentially inappropriate medications in older inpatients in China. J Am Geriatr Soc. 2014;62(11):2216–2218. doi:10.1111/jgs.1305325413197
   PubMed Web of Science ®Google Scholar
• Li H, Pu S, Liu Q, et al. Potentially inappropriate medications in Chinese older adults: the beers criteria compared with the screening tool of older persons’ prescriptions criteria. Geriatr Gerontol Int. 2017;17(11):1951–1958. doi:10.1111/ggi.1299928224703
   PubMed Web of Science ®Google Scholar
• Jirón M, Pate V, Hanson LC, Lund JL, Jonsson Funk M, Stürmer T. Trends in prevalence and determinants of potentially inappropriate prescribing in the United States: 2007 to 2012. J Am Geriatr Soc. 2016;64(4):788–797. doi:10.1111/jgs.1407727100575
   PubMed Web of Science ®Google Scholar
• Gustafsson M, Sjölander M, Pfister B, Schneede J, Lövheim H. Effects of pharmacists’ interventions on inappropriate drug use and drug-related readmissions in People with Dementia – a secondary analysis of a randomized controlled trial. Pharm (Basel). 2018;6(1):E7. doi:10.3390/pharmacy6010007
   Google Scholar
• Gillespie U, Alassaad A, Hammarlund-Udenaes M, et al. Effects of pharmacists’ interventions on appropriateness of prescribing and evaluation of the instruments’ (MAI, STOPP and STARTs’) ability to predict hospitalization – analyses from a randomized controlled trial. PLoS One. 2013;8(5):e62401. doi:10.1371/journal.pone.006240123690938
   PubMed Web of Science ®Google Scholar
• Akobeng AK. Understanding diagnostic tests 1: sensitivity, specificity and predictive values. Acta Paediatr. 2007;96(3):338–341. doi:10.1111/j.1651-2227.2006.00180.x17407452
   PubMed Web of Science ®Google Scholar
• Sumukadas D, McMurdo ME, Mangoni AA, Guthrie B. Temporal trends in anticholinergic medication prescription in older people: repeated cross-sectional analysis of population prescribing data. Age Ageing. 2014;43(4):515–521. doi:10.1093/ageing/aft19924334709
   PubMed Web of Science ®Google Scholar
• Hanlon JT, Schmader KE. The medication appropriateness index at 20: where it started, where it has been, and where it may be going. Drugs Aging. 2013;30(11):893–900. doi:10.1007/s40266-013-0118-424062215
   PubMed Web of Science ®Google Scholar